| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 98.8 | 92.4 | +7.0% |
| EBITDA | 10.8 | 10.8 | +0.4% |
| EBITDA margin | 10.9% | 11.6% | −0.7 pts |
| Profit before tax | 1.3 | 1.0 | +36.1% |
| Net profit | 1.4 | 1.1 | +28.5% |
| EPS | ₹1.81 | ₹1.41 | +28.4% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 82.6 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.4 | 0.4 | 0.6 | 0.3 | 4.0 | ||
| 267 | 267 | 261 | 279 | 196 | ||
| 349 | — | — | — | — | ||
| 368 | 362 | 359 | 367 | 365 | ||
| — | +1.0% | −2.3% | +0.6% | — | ||
| 40.8 | 40.7 | 32.3 | 31.1 | 34.2 | ||
| 11.1% | 11.3% | 9.0% | 8.5% | 9.4% | ||
| 26.0 | 25.9 | 17.6 | 20.9 | 24.5 | ||
| 5.6 | 5.3 | 4.0 | 3.2 | 12.4 | ||
| 1.5% | 1.5% | 1.1% | 0.9% | 3.4% | ||
| ₹7.38 | ₹6.97 | ₹5.36 | ₹4.26 | ₹16.46 | ||
| — | +30.1% | +26.0% | −74.2% | — | ||
| — | 21.6 | 10.8 | 18.0 | −0.0 | ||
| — | −0.8 | −8.7 | −92.6 | −53.9 | ||
| 20.9 | 20.9 | 2.1 | −74.6 | −53.9 | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 82.6 | |
| - Cash, Equiv & ST Investments | 4.0 | 0.3 | 0.6 | 0.4 | 0.4 | |
| + Total Debt | 196.3 | 278.8 | 261.1 | 266.9 | 266.9 | |
| Enterprise Value | — | — | — | — | 349.1 | |
| Revenue | 364.9 | 367.2 | 358.6 | 362.0 | 368.5 | |
| Growth %, YoY | — | +0.6 | -2.3 | +1.0 | — | |
| EBITDA | 34.2 | 31.1 | 32.3 | 40.7 | 40.8 | |
| Margin % | 9.38 | 8.46 | 9.00 | 11.25 | 11.06 | |
| EBIT | 24.5 | 20.9 | 17.6 | 25.9 | 26.0 | |
| Net Income | 12.4 | 3.2 | 4.0 | 5.3 | 5.6 | |
| Margin % | 3.40 | 0.87 | 1.13 | 1.45 | 1.51 | |
| EPS, Adj (current shares) | 16.46 | 4.26 | 5.36 | 6.97 | 7.38 | |
| Growth %, YoY | — | -74.2 | +26.0 | +30.1 | — | |
| Cash from Operations | -0.0 | 18.0 | 10.8 | 21.6 | — | |
| Capital Expenditures | -53.9 | -92.6 | -8.7 | -0.8 | — | |
| Free Cash Flow | -53.9 | -74.6 | 2.1 | 20.9 | 20.9 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Reliance Chemotex Industries (NSE: RELCHEMQ) had a market capitalisation of ₹81.4 crore at the 30 October 2026 close (₹107.96 a share), a PE ratio of 14.6 on the last four quarters' profit and a price-to-book ratio of 0.57. In FY26 its consolidated net profit was ₹5.3 crore on revenue of ₹362 crore; in Q1 FY27 (April–June 2026) it was ₹1.4 crore, up 28.5% year on year. Its debt-to-equity ratio was 1.87 on 31 March 2026. Promoters held 67.68% of the shares on 30 September 2026.
Reliance Chemotex Industries' PE ratio is 14.6 at the 30 October 2026 close (₹107.96 a share): a market capitalisation of ₹81.4 crore divided by consolidated net profit of ₹5.6 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹5.3 crore) it is 15.5.
Reliance Chemotex Industries' price-to-book (PB) ratio is 0.57 at the 30 October 2026 close: a market capitalisation of ₹81.4 crore divided by shareholders' equity (book value) of ₹143 crore on 31 March 2026. That is a book value of ₹189.23 per share against a share price of ₹107.96.
Reliance Chemotex Industries' net worth — shareholders' equity in its consolidated balance sheet — was ₹143 crore on 31 March 2026, up 4.0% from ₹137 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹81.4 crore at the 30 October 2026 close.
Reliance Chemotex Industries' market capitalisation was ₹81.4 crore at the 30 October 2026 close: 75.44 lakh shares at ₹107.96 each.
No. Reliance Chemotex Industries had borrowings of ₹267 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 1.87. Its cash and current investments were ₹12.8 crore, so its net debt was ₹254 crore.
Reliance Chemotex Industries' basic earnings per share (EPS) were ₹6.97 in FY26, against ₹5.36 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹7.37.
Reliance Chemotex Industries' debt-to-equity ratio was 1.87 on 31 March 2026: borrowings of ₹267 crore against total equity of ₹143 crore. A year earlier, on 31 March 2025, it was 1.90.
Reliance Chemotex Industries' book value per share was ₹189.23 on 31 March 2026: shareholders' equity of ₹143 crore divided by the 75.44 lakh shares in issue, up 4.0% from ₹181.99 a year earlier. The share price at the 30 October 2026 close was ₹107.96.
Promoters held 67.68% of Reliance Chemotex Industries on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Reliance Chemotex Industries' return on equity (ROE) was 3.8% and its return on capital employed (ROCE) was 8.0%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 3.0% and ROCE 5.6%.
Reliance Chemotex Industries' dividend yield is 0.46% at the 30 October 2026 close: dividends of ₹0.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹107.96. They were ₹0.50 on 18 September 2026.
On FY26 consolidated figures, against Nagreeka Exports: Reliance Chemotex Industries' operating margin of 7.2% is the higher of the two (Nagreeka Exports 3.1%; peer average 3.1%); its return on equity of 3.8% is the higher of the two (Nagreeka Exports 2.0%; peer average 2.0%); its revenue growth over three years of −0.3% a year is the lower of the two (Nagreeka Exports 9.6% a year; peer average 9.6% a year).
In 2026, Reliance Chemotex Industries has declared one dividend: ₹0.50 with record date 18 September 2026.
On 30 September 2026, Reliance Chemotex Industries' shares were held by promoters 67.68% and retail and other non-institutional investors 32.32%.
Reliance Chemotex Industries will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, the date of the board meeting it has notified to the exchanges.
In FY26, Reliance Chemotex Industries generated ₹21.6 crore of cash from operations and spent ₹78 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹20.9 crore. In FY25 it was ₹2.1 crore.
Reliance Chemotex Industries' latest results are for Q1 FY27 (April–June 2026), filed on 11 August 2026: consolidated net profit ₹1.4 crore, up 28.5% from ₹1.1 crore in Q1 FY26; revenue from operations ₹98.8 crore, up 7.0% year on year.
In FY26 (April 2025–March 2026), Reliance Chemotex Industries' consolidated net profit was ₹5.3 crore, up 30.1% from ₹4 crore in FY25, on revenue from operations of ₹362 crore (up 1.0%). Over three years, from FY23, net profit was down 57.6%.
At the 30 October 2026 closing prices, on FY26 net profit, Reliance Chemotex Industries' PE ratio is 15.5, the lower of the two: Nagreeka Exports 20.8, a peer average of 20.8. Each is the company's market capitalisation at that price divided by its FY26 net profit.
In FY26, Reliance Chemotex Industries earned net profit of ₹5.3 crore on revenue of ₹362 crore, against ₹3.1 crore on ₹511 crore for Nagreeka Exports. Reliance Chemotex Industries' operating margin was 7.2% (Nagreeka Exports 3.1%) and its return on equity 3.8% (Nagreeka Exports 2.0%). At the 30 October 2026 close, Reliance Chemotex Industries' market capitalisation was ₹81.4 crore against ₹63.8 crore for Nagreeka Exports, and its PE ratio on FY26 profit 15.5 against 20.8.
From Reliance Chemotex Industries' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.